Risk for chronic kidney disease (CKD) among Olmsted County, MN, stone formers and control subjects. Risk for chronic kidney disease (CKD) among Olmsted.

Slides:

Advertisements

Similar presentations

A.M. Thompson, T.G. Pickering Kidney International

Advertisements

Golden Rules to Keep Kidneys Healthy

Volume 67, Pages S1-S7 (June 2005)

Among Medicare beneficiaries >65 years old with a index hospitalization at the time of dialysis initiation, use of post-acute SNF care was common. Among.

SAVE: Risk of total mortality associated with reduced kidney function

Positive interactions between the basic and translational research, clinical research, patient care, and training components of an academic dialysis access.

Figure 1.17 of the 2016 US Renal Data System Annual Data Report, Volume 2, chapter 1 showing the trends in the number of patients with incident ESRD (in.

Mitchell H. Rosner, W. Kline Bolton Kidney International

Volume 83, Issue 3, Pages (March 2013)

Probability of cumulative incidence of ESRD, disease-related death, or death from other cause for the entire cohort. Probability of cumulative incidence.

John P. Middleton, Patrick H. Pun Kidney International

Comorbidity status in patients with CKD stage 4 or 5 not on dialysis, peritoneal dialysis, haemodialysis and transplanted patients (bars), as well as in.

The incidence of all cause graft failure, and death with a functioning graft was higher in patients who received a DCD donor transplant with total donor.

Sabina Kersting, Leo F. Verdonck

Patterns of mortal risk among eKt/V quintiles in the HEMO study for (A) 1 yr of follow-up and (B) after 1 yr. Patterns of mortal risk among eKt/V quintiles.

Adjusted rate ratios of hospital days and admissions for blacks and Hispanics compared with whites by age group. Adjusted rate ratios of hospital days.

End-stage renal disease in living kidney donors

Volume 69, Issue 2, Pages (January 2006)

Anemia as a risk factor for chronic kidney disease

D. Batlle, P. Ramadugu, M.J. Soler Kidney International

Cumulative incidence of (A) ESRD, (B) all-cause death, (C) all-cause death without ESRD and (D) ESRD or all-cause death in patients with T1DM diagnosed.

Volume 70, Issue 11, Pages (December 2006)

Long-term outcomes in nondiabetic chronic kidney disease

Stephen P. McDonald Kidney International Supplements

Sabina Kersting, Ronald J. Hené, Hein A. Koomans, Leo F. Verdonck

Volume 73, Issue 12, Pages (June 2008)

Conceptual model of the natural history of diabetic kidney disease.

Three-year cumulative incidence of a gout diagnosis presented by level of kidney function and sex. Three-year cumulative incidence of a gout diagnosis.

Volume 76, Issue 8, Pages (October 2009)

Box plots showing the relative difference in distribution of mtDNA copy number per cell between patients with ESRD and healthy control subjects frequency.

Forest plot showing the association between center-level characteristics and death-censored technique failure after adjusting for age, sex, race, body.

Incidence of contrast-induced nephropathy in patients with CKD, normal kidney function and all patients. Incidence of contrast-induced nephropathy in patients.

Unraveling the racial disparities associated with kidney disease1

Volume 76, Issue 6, Pages (September 2009)

Kaplan–Meier curve for technique survival censored for death, transplantation, and program exit for patient choice for all individuals commencing home.

Conceptual model of the course of chronic kidney disease (CKD).

Cumulative incidence of cardiovascular events according to medication group in participants of the 4D study with an LDL-C in its fourth quartile at baseline.

Cardiovascular risk in chronic kidney disease

Representative transaxial thin computed tomography (CT) sections at mid, mid-low, and low levels of the heart from a control subject (left) showing normal.

Seven-year cumulative incidence of ESRD according to baseline creatinine clearance (Ccr) and result of urine test for proteinuria (19). Seven-year cumulative.

Renal replacement therapy in Latin America

Calcifications in autosomal dominant polycystic kidneys.

Immunosuppression significantly reduced all-cause mortality or risk of ESRD (A) and significantly increased complete or partial remission (B) at the end.

Ionized-to-total magnesium (Mg) and calcium (Ca) ratios are lower in patients on hemodialysis than those in patients not on dialysis. Ionized-to-total.

Ca2+ infusion rates during all three protocol versions.

Volume 88, Issue 5, Pages (November 2015)

Diagram of the mechanisms involved in limiting the ability of the kidney to maintain the levels of 1,25-dihydroxyvitamin D in chronic kidney disease (CKD).

Area under the curve (AUC)–targeted dosing of carboplatin using either the Cockcroft–Gault formula or the Chronic Kidney Disease Epidemiology Collaboration.

A loading dose decreases the time to achieve the target concentration.

Risk differences for incident stroke, coronary heart disease (CHD), and cardiovascular mortality (per 1000 person-years) by clinical risk factor in the.

Response to cyclosporin A (CsA) treatment and renal outcome in patients with either nongenetic or genetic disease. Response to cyclosporin A (CsA) treatment.

Potential links between the immune dysfunction in uremia, inflammation, infection, and increased risk of atherosclerosis and cardiovascular disease. Potential.

Authors’ concept of aortic stiffness in relation to other cardiovascular risk factors. Authors’ concept of aortic stiffness in relation to other cardiovascular.

Incidence of normal glucose tolerance (NGT), impaired glucose tolerance (IGT), new-onset diabetes (NODMM), and cumulative transplant-associated hyperglycemia.

Distribution of vascular access type (2002–2011) among countries with stable or decreasing catheter burden over time. Distribution of vascular access type.

Stephen Pastan, J. Michael Soucie, William M. McClellan

Mortality caused by cardiovascular disease (A) and sepsis (B) of patients with end-stage renal disease (ESRD) treated by dialysis compared with the general.

Cumulative mortality risk in patients with 48-h blood urea nitrogen (BUN) levels of ≥8 mg/dl or

By estimating per-month expenditures for patients aged 45 to 64 as 85% of those documented in a 67-yr-old, it is possible to approximate the financial.

Comparison of Medicare reimbursement to a nephrology practice on an annual per-patient basis for care of a patient on dialysis (at two different frequencies.

Association between hyperphosphatemia (serum phosphorus ≥4

New dialysis starts in the United States by year in patients with and without diagnosis of diabetes. New dialysis starts in the United States by year in.

Bias with estimated GFR (eGFR) by age (years).

Causal diagrams that represent three possible relationships between smoking, ESRD, and albumin-to-creatinine ratio (ACR) in the Study of Heart and Renal.

As the patient nears the end of life (dashed arrow), there is an increasing focus on symptom control and patient goals of care and a shift in the approach.

Grayscale ultrasonographic image in CKD

Fistula and Survival Outcomes after Fistula Creation among Predialysis Chronic Kidney Disease Stage 5 Patients Miyamoto et al. Am J Nephrol 2017;45:

Pancreas transplantation is performed at transplant centers within 56 of the 58 federally designated donor service areas (DSAs). Pancreas transplantation.

Posttransplantation cumulative survival for adult living-donor liver transplantation (LDLT) recipients without thrombotic microangiopathy (TMA; n = 220)

The pretest probability of disease decreases with age in individuals who are born with 50% risk for autosomal dominant polycystic kidney disease (ADPKD)

Presentation transcript:

Risk for chronic kidney disease (CKD) among Olmsted County, MN, stone formers and control subjects. Risk for chronic kidney disease (CKD) among Olmsted County, MN, stone formers and control subjects. (A through D) Cumulative incidence for any CKD diagnostic code (518 stone formers and 189 control subjects at risk at 18 yr, A); ESRD by dialysis or kidney transplant or death with CKD (577 stone formers and 229 control subjects at risk at 18 yr, B); and a sustained elevated SCr level with censoring by last clinic visit in Olmsted County (610 stone formers and 236 control subjects at risk at 18 yr, C) or with censoring by last SCr level at the Mayo Clinic (226 stone formers and 102 control subjects at risk at 18 yr, D). Andrew D. Rule et al. CJASN 2009;4:804-811 ©2009 by American Society of Nephrology